Top

Published in:

01-02-2019 | Low Molecular Weight Heparin | Editorial

Observational vs randomized: David vs Goliath for thromboprophylaxis in critically ill patients?

Authors: Julie Helms, Julian Bion, Audrey De Jong

Published in: Intensive Care Medicine | Issue 2/2019

Excerpt

In their article in Intensive Care Medicine, Stelfox et al. [1] report the impact of a multicomponent implementation intervention on the clinical practice of pharmacological venous thromboembolism (VTE) prophylaxis, related outcomes, and healthcare utilization among patients admitted to 11 Canadian ICUs. Their intervention resulted in a 32.4% increase in the administration of low molecular weight heparin (LMWH) over unfractionated heparin (UFH) over the course of 12 months in the intervention group (five ICUs), significantly more than in the control group (15.4%). …

Stelfox HT, Brundin-Mather R, Soo A, Parsons Leigh J, Niven DJ, Fiest KM, Doig CJ, Zuege DJ, Kushner B, Clement F, Straus SE, Cook DJ, Bagshaw SM, Sauro KM (2019) A multicentre controlled pre–post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients. Intensive Care Med. https://doi.org/10.1007/s00134-019-05532-1

Cook D, Crowther M, Meade M, Rabbat C, Griffith L, Schiff D, Geerts W, Guyatt G (2005) Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med 33:1565–1571CrossRefPubMed

Alhazzani W, Lim W, Jaeschke RZ, Murad MH, Cade J, Cook DJ (2013) Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med 41:2088–2098CrossRefPubMed

Cook D, Meade M, Guyatt G, Walter S, Heels-Ansdell D, Warkentin TE, Zytaruk N, Crowther M, Geerts W, Cooper DJ, Vallance S, Qushmaq I, Rocha M, Berwanger O, Vlahakis NE (2011) Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med 364:1305–1314CrossRefPubMed

De Jong A, Clavieras N, Conseil M, Coisel Y, Moury PH, Pouzeratte Y, Cisse M, Belafia F, Jung B, Chanques G, Molinari N, Jaber S (2014) Implementation of a combo videolaryngoscope for intubation in critically ill patients: a before-after comparative study. Intensive Care Med 39:2144–2152CrossRef

Landelle C, Nocquet Boyer V, Abbas M, Genevois E, Abidi N, Naimo S, Raulais R, Bouchoud L, Boroli F, Terrisse H, Bosson JL, Harbarth S, Pugin J (2018) Impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination. Intensive Care Med 44:1777–1786CrossRefPubMedPubMedCentral

Zhu B, Li Z, Jiang L, Du B, Jiang Q, Wang M, Lou R, Xi X (2015) Effect of a quality improvement program on weaning from mechanical ventilation: a cluster randomized trial. Intensive Care Med 41:1781–1790CrossRefPubMed

de Jong A, Molinari N, de Lattre S, Gniadek C, Carr J, Conseil M, Susbielles MP, Jung B, Jaber S, Chanques G (2013) Decreasing severe pain and serious adverse events while moving intensive care unit patients: a prospective interventional study (the NURSE-DO project). Crit Care 17:R74CrossRefPubMedPubMedCentral

Timsit JF, de Kraker MEA, Sommer H, Weiss E, Bettiol E, Wolkewitz M, Nikolakopoulos S, Wilson D, Harbarth S (2017) Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE’s STAT-Net. Intensive Care Med 43:1002–1012CrossRefPubMedPubMedCentral

10.

Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D (2002) Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 27:299–309CrossRefPubMed

11.

Pagoto SL, Lemon SC (2013) Efficacy vs effectiveness. JAMA Intern Med 173:1262–1263CrossRefPubMed

12.

Glasgow RE, Lichtenstein E, Marcus AC (2003) Why don’t we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. Am J Public Health 93:1261–1267CrossRefPubMedPubMedCentral

13.

Flay BR (1986) Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs. Prev Med 15:451–474CrossRefPubMed

14.

Bailly S, Meyfroidt G, Timsit JF (2018) What’s new in ICU in 2050: big data and machine learning. Intensive Care Med 44:1524–1527CrossRefPubMed

15.

Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887–1892CrossRefPubMedPubMedCentral

Title: Observational vs randomized: David vs Goliath for thromboprophylaxis in critically ill patients?
Authors: Julie Helms
Julian Bion
Audrey De Jong
Publication date: 01-02-2019
Publisher: Springer Berlin Heidelberg
Keyword: Low Molecular Weight Heparin
Published in: Intensive Care Medicine / Issue 2/2019
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-019-05541-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Observational vs randomized: David vs Goliath for thromboprophylaxis in critically ill patients?

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2019

Frugal innovation for critical care

Rationalizing antimicrobial therapy in the ICU: a narrative review

Physiological interventions in cardiac arrest: passing the pilot phase

Oxygen and carbon dioxide targets during and after resuscitation of cardiac arrest patients

Mechanism of airway closure in acute respiratory distress syndrome: a possible role of surfactant depletion

This is not a drill